Geneva Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.04M	Sell	4,146 -785	-16%	-$426K	0.04%	109
2025 Q4	$2.86M	Sell	4,931 -51	-1%	-$28.8K	0.05%	105
2025 Q3	$2.42M	Sell	4,982 -191	-4%	-$88.9K	0.04%	110
2025 Q2	$2.1M	Buy	5,173 +636	+14%	+$266K	0.04%	111
2025 Q1	$2.26M	Sell	4,537 -79	-2%	-$42.8K	0.04%	109
2024 Q4	$2.4M	Sell	4,616 -332	-7%	-$183K	0.04%	115
2024 Q3	$3.06M	Sell	4,948 -430	-8%	-$255K	0.05%	111
2024 Q2	$2.97M	Sell	5,378 -1,341	-20%	-$768K	0.05%	113
2024 Q1	$3.91M	Sell	6,719 -336	-5%	-$189K	0.07%	106
2023 Q4	$3.74M	Sell	7,055 -354	-5%	-$171K	0.07%	104
2023 Q3	$3.75M	Buy	7,409 +644	+10%	+$343K	0.08%	106
2023 Q2	$3.53M	Sell	6,765 -287	-4%	-$155K	0.07%	105
2023 Q1	$4.06M	Sell	7,052 -526	-7%	-$296K	0.08%	102
2022 Q4	$4.17M	Sell	7,578 -822	-10%	-$436K	0.09%	104
2022 Q3	$4.26M	Sell	8,400 -3	-0%	-$1.68K	0.1%	106
2022 Q2	$4.57M	Sell	8,403 -93	-1%	-$51.2K	0.11%	104
2022 Q1	$5.02M	Buy	8,496 +106	+1%	+$60.9K	0.1%	111
2021 Q4	$5.6M	Sell	8,390 -201	-2%	-$125K	0.09%	108
2021 Q3	$4.91M	Sell	8,591 -254	-3%	-$139K	0.08%	112
2021 Q2	$4.46M	Sell	8,845 -36	-0.4%	-$17K	0.07%	112
2021 Q1	$4.05M	Sell	8,881 -91	-1%	-$43.4K	0.07%	114
2020 Q4	$4.18M	Buy	8,972 +12	+0.1%	+$5.63K	0.07%	113
2020 Q3	$3.96M	Buy	8,960 +79	+0.9%	+$32.6K	0.08%	107
2020 Q2	$3.22M	Buy	8,881 +79	+0.9%	+$26.5K	0.07%	108
2020 Q1	$2.5M	Buy	+8,802	New	+$2.78M	0.07%	110